New test could flag which men need aggressive prostate cancer treatment and which don't
Top Story
Archived
•
October 26, 2026
•
The Decipher genomic test could help doctors decide which high-risk prostate cancer patients need abiraterone hormone therapy and which can skip it.
Source: FoxNews | https://feeds.feedburner.com/foxnews/latest - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!


